Company intelligence / Profile preview
Wolwo Biotech
- Ownership
- Private
- Employees
- ~1200
- Development stage
- Other
Overview
Wolwo Biotech is a leading Chinese biopharmaceutical company specializing in the research, development, and commercialization of allergy diagnostic and therapeutic products. The company is best known for its sublingual immunotherapy (SLIT) products, specifically its flagship Dermatophagoides farinae drops (Chan Di) used to treat allergic rhinitis and asthma. Wolwo Biotech maintains a dominant position in the Chinese desensitization market and continues to expand its portfolio with pollen-based immunotherapy and skin prick diagnostic reagents. Its business model focuses on providing comprehensive solutions for allergic diseases, from diagnosis to long-term treatment.
- Therapeutic areas
- ImmunologyDermatology
- Modalities
- BiologicProteinVaccineSmall molecule
- Industry
- Biotech
Drug pipeline
18 assets17 more assets in the full pipeline.
Beyond the preview
Go deeper on Wolwo Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wolwo Biotech.